 | Up a level |
Thuijs, Daniel J F M; Kappetein, A Pieter; Serruys, Patrick W; Mohr, Friedrich-Wilhelm; Morice, Marie-Claude; Mack, Michael J; Holmes, David R; Curzen, Nick; Davierwala, Piroze; Noack, Thilo; Milojevic, Milan; Dawkins, Keith D; Da Costa, Bruno R; Jüni, Peter; Head, Stuart J (2019). Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet, 394(10206), pp. 1325-1334. Elsevier 10.1016/S0140-6736(19)31997-X
Linke, Axel; Wenaweser, Peter Martin; Gerckens, Ulrich; Tamburino, Corrado; Bosmans, Johan; Bleiziffer, Sabine; Blackman, Daniel; Schäfer, Ulrich; Müller, Ralf; Sievert, Horst; Søndergaard, Lars; Klugmann, Silvio; Hoffmann, Rainer; Tchétché, Didier; Colombo, Antonio; Legrand, Victor M; Bedogni, Francesco; lePrince, Pascal; Schuler, Gerhard; Mazzitelli, Domenico; ... (2014). Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. European Heart Journal, 35(38), pp. 2672-2684. Oxford University Press 10.1093/eurheartj/ehu162
Yan, Tristan D; Tian, David H; LeMaire, Scott A; Misfeld, Martin; Elefteriades, John A; Chen, Edward P; Hughes, G Chad; Kazui, Teruhisa; Griepp, Randall B; Kouchoukos, Nicholas T; Bannon, Paul G; Underwood, Malcolm J; Mohr, Friedrich-Wilhelm; Oo, Aung; Sundt, Thoralf M; Bavaria, Joseph E; Di Bartolomeo, Roberto; Di Eusanio, Marco; Roselli, Eric E; Beyersdorf, Friedhelm; ... (2014). The ARCH Projects: design and rationale (IAASSG 001). European journal of cardio-thoracic surgery, 45(1), pp. 10-16. Oxford University Press 10.1093/ejcts/ezt520
Grube, Eberhard; Schuler, Gerhard; Buellesfeld, Lutz; Gerckens, Ulrich; Linke, Axel; Wenaweser, Peter; Sauren, Barthel; Mohr, Friedrich-Wilhelm; Walther, Thomas; Zickmann, Bernfried; Iversen, Stein; Felderhoff, Thomas; Cartier, Raymond; Bonan, Raoul (2007). Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. Journal of the American College of Cardiology, 50(1), pp. 69-76. New York, N.Y.: Elsevier 10.1016/j.jacc.2007.04.047
